Litcius/Paper detail

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment

Angela M. Araujo, Andrea Abaurrea, Peio Azcoaga, Joanna I. López-Velazco, Sara Manzano, Javier Rodríguez, Ricardo Rezola, Leire Egia‐Mendikute, Fátima Valdés‐Mora, Juana M. Flores, Liam Jenkins, Laura Pulido, Iñaki Osorio-Querejeta, Patricia Fernández‐Nogueira, Nicola Ferrari, Cristina Viera, Natalia Martín-Martín, Alexandar Tzankov, Serenella Eppenberger‐Castori, Isabel Álvarez, Ander Urruticoechea, Paloma Bragado, Nicholas Coleman, Asís Palazón, Arkaitz Carracedo, David Gallego‐Ortega, Fernando Calvo, Clare M. Isacke, María M. Caffarel, Charles H. Lawrie

2022Journal of Clinical Investigation30 citationsDOIOpen Access PDF

Topics & Concepts

Oncostatin MStromal cellReprogrammingTumor microenvironmentCancer researchCytokineBreast cancerMedicineTumor progressionCancerBiologyPathologyInterleukin 6ImmunologyTumor cellsInternal medicineCellGeneticsCytokine Signaling Pathways and InteractionsChemokine receptors and signalingCancer, Lipids, and Metabolism
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment | Litcius